PHARMA PROJECTS
Optimal Futures for Risk Evaluation and Mitigation Strategies (REMS)
In September 2009, in conjunction with the Society for Women's Health Research, IAF facilitated a workshop of regulators, industry, academics, and consumer advocates to explore the optimal futures for the FDA's new Risk Evaluation and Mitigation Strategies (REMS). View the PDF report here.
Co-evolution: Innovation and Regulation of Medical Products
IAF facilitated a meeting of leaders from regulation and industry to explore the future environment for the innovation and regulation of medical products. Participants used a series of thirteen forecasts for the next decade to stimulate thinking. Click here to see the report.
The 2029 Project: Achieving an Ethical Future for Biomedical R&D
This project showcases the dramatic advances that are likely to occur over the next 25 years across the spectrum of biomedical research and development activities. It forecasts that a wide array of achievements in science will be enabled by an ethical evolution. After scanning the scientific literature, interviewing dozens of scientists and holding meetings focused on 2029, IAF anticipates a culture change. An emerging ethical concern for global health will create the context for medical science to realize its full potential, which will culminate in a Health Advocate Avatar. Click here for the executive summary or here for the full report (large file).